Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Anne E. Wiktor"'
Autor:
Frank A. Sinicrope, Robert B. Jenkins, Robert B. Diasio, Tsung-Teh Wu, Axel Grothey, Christopher A. Sattler, Maliha Khan, Anne E. Wiktor, William R. Sukov, Qian Shi, Harry H. Yoon
PDF file - 790K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c8ab9952698b42ad574a64d5a33914c
https://doi.org/10.1158/1078-0432.22443185
https://doi.org/10.1158/1078-0432.22443185
Autor:
Frank A. Sinicrope, Robert B. Jenkins, Robert B. Diasio, Tsung-Teh Wu, Axel Grothey, Christopher A. Sattler, Maliha Khan, Anne E. Wiktor, William R. Sukov, Qian Shi, Harry H. Yoon
Purpose: We examined the frequency, tumor characteristics, and prognostic impact of HER2 protein expression and gene amplification in patients with curatively resected esophageal adenocarcinoma (EAC).Experimental Design: HER2 expression was analyzed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dec9967d1363fee8d0978632042d1e1
https://doi.org/10.1158/1078-0432.c.6519704.v1
https://doi.org/10.1158/1078-0432.c.6519704.v1
Autor:
William R. Sukov, Harry H. Yoon, Marie Holubek, Anne E. Wiktor, Tsung-Teh Wu, Robert B. Jenkins, Zhaohui Jin, Christopher A. Sattler
Publikováno v:
American journal of clinical oncology. 42(2)
BACKGROUND: Our purpose was to evaluate the prognostic impact of pathologically-confirmed esophageal adenosquamous carcinoma (ASC) and its association with HER2 status and clinicopathologic characteristics. METHODS: Among 796 patients with esophageal
Autor:
William R. Sukov, Stefan J. Green, Anne E. Wiktor, Karla V. Ballman, Kathleen S. Tenner, Rhett P. Ketterling, Reid G. Meyer, Mithun Vinod Shah, Edith A. Perez, Robert B. Jenkins
Publikováno v:
Journal of Clinical Oncology. 34:3502-3510
Purpose In 1998, the US Food and Drug Administration (FDA) approved human epidermal growth factor receptor 2 (HER2) testing guidelines to determine eligibility for HER2-directed therapy (HDT) in breast cancer. ASCO and the College of American Patholo
Autor:
Anne E. Wiktor, Harry H. Yoon, Mark A. Lewis, Robert B. Jenkins, Nathan R. Foster, Christopher A. Sattler, Maliha Khan, William R. Sukov, Tsung Teh Wu, Frank A. Sinicrope
Publikováno v:
International Journal of Cancer. 139:1626-1631
Although HER2-positive breast cancers demonstrate a propensity for central nervous system (CNS) metastasis, it is unknown whether other HER2-positive tumors, including adenocarcinomas of the esophagus/gastroesophageal junction (EAC), share this chara
Autor:
Richard D. Hammer, Mark R. Litzow, Curtis A. Hanson, Rong He, Daniel L. Van Dyke, Paul J. Kurtin, Anne E. Wiktor, Donald C. Doll, Rhett P. Ketterling, Lester J. Layfield, Kaaren K. Reichard, Matthew T. Howard
Publikováno v:
American Journal of Clinical Pathology. 145:430-432
We read with interest the recent article by He et al1 comparing conventional karyotyping and fluorescence in situ hybridization (FISH) in acute myeloid leukemia (AML). While the authors clearly show no advantage to FISH when karyotyping is adequate a
Autor:
Andre M. Oliveira, Jennelle C. Hodge, Patricia T. Greipp, Xiaoke Wang, Anne E. Wiktor, Kathryn E. Pearce
Publikováno v:
Modern Pathology. 27:113-127
Renal cell carcinoma with TFE3 rearrangement at Xp11.2 is a distinct subtype manifesting an indolent clinical course in children, with recent reports suggesting a more aggressive entity in adults. This subtype is morphologically heterogeneous and can
Autor:
James T, Mascarello, Betsy, Hirsch, Hutton M, Kearney, Rhett P, Ketterling, Susan B, Olson, Denise I, Quigley, Kathleen W, Rao, James H, Tepperberg, Karen D, Tsuchiya, Anne E, Wiktor
Publikováno v:
Genetics in Medicine. 21:2405
Autor:
Anne E. Wiktor, Christopher A. Sattler, Robert B. Diasio, Robert B. Jenkins, Tsung Teh Wu, William R. Sukov, Frank A. Sinicrope, Qian Shi, Harry H. Yoon
Publikováno v:
Cancer. 120:415-424
BACKGROUND Human epidermal growth factor receptor 2 (HER2) is a therapeutic target in patients with esophageal adenocarcinoma (EAC), with gene amplification used as a selection criterion for treatment, although to the authors' knowledge the concordan
Autor:
William R. Sukov, Aaron S. Mansfield, Ahmet Dogan, Anne E. Wiktor, FJ Walsh, Y Sakai, Robert B. Jenkins
Publikováno v:
Cancer Research. 72:PD02-05
Introduction: The appropriate assessment of HER2 amplification status is critical to determining which patients should receive HER2-directed therapy. An alternative to FISH is D-ISH (Ventana Medical Systems Tucson, Arizona) which utilizes chromogenic